Maple
Financials
Estimates*
USD | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Revenues | 4.1m | 10.2m | 17.9m | 20.3m | 23.3m |
% growth | - | 149 % | 75 % | 13 % | 15 % |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $100k | Angel | |
N/A | $1.5m | Seed | |
$4.0m | Seed | ||
N/A | - | ||
$14.5m | Series A | ||
* | CAD75.0m | Early VC | |
Total Funding | $75.1m |
Recent News about Maple
EditMaple is a Canadian-based startup operating in the healthcare sector, specifically in the telemedicine market. The company provides a virtual platform that allows patients to consult with Canadian-licensed doctors anytime, anywhere. This service is particularly beneficial for those who struggle to find a family doctor or need medical attention outside regular office hours.
Maple's business model is centered on providing on-demand healthcare services 24/7. Patients can either book an appointment with a specialist or get immediate virtual care. The platform also offers access to specialty care, including mental health, dermatology, and pediatric primary care.
The company generates revenue by charging for the consultations. The cost varies depending on the type of consultation, with immediate virtual care being more expensive than scheduled appointments. The platform is highly rated by users, boasting over 800,000 five-star reviews, which indicates a high level of customer satisfaction and trust in the service.
Maple's services are not only convenient but also efficient. Patients have reported getting their prescriptions within minutes and being able to complete processes that would typically require a referral and a six-month wait in less than 72 hours. This efficiency, coupled with the convenience of accessing healthcare services from the comfort of home, positions Maple as a valuable player in the telemedicine market.
Keywords: Telemedicine, Healthcare, Virtual Care, On-Demand, 24/7 Service, Canadian-Licensed Doctors, Specialty Care, Customer Satisfaction, Efficiency, Convenience.